Suscribirse

Differentiation between adrenocortical carcinoma and lipid-poor adrenal adenoma using a multiparametric MRI-based diagnostic algorithm - 04/04/24

Doi : 10.1016/j.diii.2024.03.005 
Carmelia Oloukoi a, b, Anthony Dohan a, b, c, Martin Gaillard b, c, d, Christine Hoeffel e, Lionel Groussin-Rouiller b, c, f, Jérome Bertherat b, c, f, Anne Jouinot b, c, f, Guillaume Assié b, c, f, David Fuks b, d, Mathilde Sibony b, g, Philippe Soyer a, b, Anne-Sophie Jannot h, i, Maxime Barat a, b, c,
a Department of Radiology, Hôpital Cochin, AP-HP, 75014 Paris, France 
b Université Paris Cité, Faculté de Médecine, 75006 Paris, France 
c Génomique et Signalisation des Tumeurs Endocrines, Institut Cochin, INSERM U 1016, CNRS UMR8104, Université Paris Cité, 75014 Paris, France 
d Department of Pancreatic and Endocrine Surgery, Hôpital Cochin, AP-HP, 75014 Paris, France 
e Department of Radiology, Hôpital Robert Debré, CRESTIC, URCA, 51000 Reims, France 
f Department of Endocrinology, Hôpital Cochin, AP-HP, 75014 Paris, France 
g Department of Pathology, Hôpital Cochin, AP-HP, 75014 Paris, France 
h AP-HP.Centre- Université Paris Cité, Hôpital Européen Georges Pompidou, Medical Informatics, Biostatistics and Public Health Department, 75015, Paris, France 
i INSERM, UMR_S1138, Cordeliers Research Center, Université Paris Cité, 75006 Paris, France 

Corresponding author.
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Thursday 04 April 2024

Highlights

A diagnostic algorithm combining signal intensity index on chemical-shift imaging and apparent diffusion coefficient value on diffusion-weighted imaging helps discriminate between lipid-poor adrenal adenoma and adrenocortical carcinoma with 75% accuracy.
Best sensitivity (96%) for the diagnosis of adrenocortical carcinoma vs. lipid-poor adrenal adenoma is obtained using the association of the diagnostic algorithm with adrenal lesion size.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to evaluate the capabilities of multiparametric magnetic resonance imaging (MRI) in differentiating between lipid-poor adrenal adenoma (LPAA) and adrenocortical carcinoma (ACC).

Materials and methods

Patients of two centers who underwent surgical resection of LPAA or ACC after multiparametric MRI were retrospectively included. A training cohort was used to build a diagnostic algorithm obtained through recursive partitioning based on multiparametric MRI variables, including apparent diffusion coefficient and chemical shift signal ratio (i.e., tumor signal intensity index). The diagnostic performances of the multiparametric MRI-based algorithm were evaluated using a validation cohort, alone first and then in association with adrenal tumor size using a cut-off of 4 cm. Performances of the diagnostic algorithm for the diagnosis of ACC vs. LPAA were calculated using pathology as the reference standard.

Results

Fifty-four patients (27 with LPAA and 27 with ACC; 37 women; mean age, 48.5 ± 13.3 [standard deviation (SD)] years) were used as the training cohort and 61 patients (24 with LPAA and 37 with ACC; 47 women; mean age, 49 ± 11.7 [SD] years) were used as the validation cohort. In the validation cohort, the diagnostic algorithm yielded best accuracy for the diagnosis of ACC vs. LPAA (75%; 46/61; 95% CI: 55–88) when used without lesion size. Best sensitivity was obtained with the association of the diagnostic algorithm with tumor size (96%; 23/24; 95% CI: 80–99). Best specificity was obtained with the diagnostic algorithm used alone (76%; 28/37; 95% CI: 60–87).

Conclusion

A multiparametric MRI-based diagnostic algorithm that includes apparent diffusion coefficient and tumor signal intensity index helps discriminate between ACC and LPAA with high degrees of specificity and accuracy. The association of the multiparametric MRI-based diagnostic algorithm with adrenal lesion size helps maximize the sensitivity of multiparametric MRI for the diagnosis of ACC.

El texto completo de este artículo está disponible en PDF.

Keywords : Adrenal gland disease, Adrenal gland neoplasm, Adrenocortical carcinoma, Diagnostic algorithm, Magnetic resonance imaging

List of abbreviations : AA, ACC, ADC, AL, ALR, APW, ASR, CI, CT, DWI, FS, GBCA, HASTE, HU, IP, IQR, LPAA, MRI, OP, PET, ROI, RPW, SD, SI, SII, TSE


Esquema


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.